Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography

Sponsor

Fox Chase Cancer Center (Other)

Overall Status

Completed

CT.gov ID

NCT04290585

Collaborator

National Cancer Institute (NCI) (NIH)

160

Enrollment

Location

Arm

42.9

Actual Duration (Months)

3.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This pilot clinical trial studies how well technology and health communication works in improving health outcomes in patients scheduled for mammography screening. The Mobile Mammography Screening Program provides a vital health service and it is important that all women scheduled for an appointment show-up to be screened. Technology and health communication may help decrease no-show rates among patients scheduled for mammography screening.

Condition or Disease	Intervention/Treatment	Phase
Female Breast Carcinoma Healthy Subject	Other: Questionnaire Administration Behavioral: Telephone-Based Intervention	N/A

Detailed Description

PRIMARY OBJECTIVES:

To decrease the mobile mammography unit no-show rate by sending text message appointment reminders to patients.
To assess the efficacy of the text message reminders at addressing the no-show rate by collecting satisfaction survey data from patients that received the texts and that came to their scheduled appointment.

OUTLINE:

Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.

Study Design

Study Type:

Interventional

Actual Enrollment :

160 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Health Services Research

Official Title:

Text for Health: Integrating Technology and Health Communication to Improve Health Outcomes (Part 2 of 2)

Actual Study Start Date :

Mar 5, 2014

Actual Primary Completion Date :

Oct 28, 2014

Actual Study Completion Date :

Oct 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Health Services Research (text message reminder) Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.	Other: Questionnaire Administration Ancillary studies Behavioral: Telephone-Based Intervention Receive text message reminders

Arm

Intervention/Treatment

Experimental: Health Services Research (text message reminder)

Patients receive 1-2 text messages a few weeks before and 1 text message 24 hours before their mammography screening appointment. Patients also receive a phone call reminder as per standard practice.

Other: Questionnaire Administration

Ancillary studies

Behavioral: Telephone-Based Intervention

Receive text message reminders

Outcome Measures

Primary Outcome Measures

Change in no-show rate pre- and post-intervention [Baseline to up to 1 year]
The change (or lack of change) in the corporate sites? no-show rate will be compared to the change (or lack of change) in the community sites? no-show rate. Descriptive statistics will be used to describe the results.

Secondary Outcome Measures

Acceptability of using text messaging as a reminder: survey [Up to 1 year]
Descriptive statistics will be used to report the results of the satisfaction survey.

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Appointment is at a participating location
Has a cell phone that can send and receive text messages
Agrees to receive the text messages
Can read either English or Spanish
Not yet sent text messages to 100 patients in community or corporate sites
Scheduled at least 1 week prior to the appointment date
PATIENTS FOR FOLLOW UP: come to their scheduled appointment
PATIENTS FOR FOLLOW UP: received the text message reminders
PATIENTS FOR FOLLOW UP: can read either English or Spanish

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Fox Chase Cancer Center	Philadelphia	Pennsylvania	United States	19111

Sponsors and Collaborators

Fox Chase Cancer Center
National Cancer Institute (NCI)

Investigators

Principal Investigator: Nestor Esnaola, Fox Chase Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Fox Chase Cancer Center

ClinicalTrials.gov Identifier:

NCT04290585

Other Study ID Numbers:

IRB13858
NCI-2015-02088
IRB13858
P30CA006927

First Posted:

Mar 2, 2020

Last Update Posted:

Mar 2, 2020

Last Verified:

Feb 1, 2020

Additional relevant MeSH terms:

Breast Neoplasms

Study Results

No Results Posted as of Mar 2, 2020